INTRODUCTION {#sec1}
============

Pleuro-pulmonary infection (PPI) is a common entity which are mainly caused by bacteria. A wide range of microorganisms can cause PPI, although the most common bacteria that are involved in immunocompetent adults in the community adquired setting include *Streptococcus pneumoniae*, *Mycoplasma pneumoniae*, viruses and *Chlamydophila pneumoniae* \[[@cit0001]\]. In elderly patients and in those with other underlying diseases *Haemophilus influenzae*, *Legionella pneumophila* and *Moraxella catarrhalis* may be also causes of PPIs \[[@cit0001]\]. *Streptococcus milleri* group is mainly associated with abscesses and supurated infections and is an uncommon cause of PPI. This group is currently known as *Streptococcus anginosus* group (SAG), term suggested by Kawamura et al. \[[@cit0002]\], and includes *S. anginosus*, *S. constellatus*, and *S. intermedius*. Of them, *S. constellatus* is generally isolated from samples of respiratory tract. However, *S. intermedius* is mainly involved with both liver and cerebral abscesses \[[@cit0003],[@cit0004]\]. Until now, only few cases of PPI due to *S. intermedius* have been reported in the medical literature \[[@cit0005]-[@cit0010]\]. Another study shows 14 patients with PI due to *S. intermedius* in a period of 10 years \[[@cit0011]\].

In the last 3 years, we have diagnosed in our laboratory 9 cases of PPI caused by *S. intermedius*. Due to its rarity, the literature has provided only limited guidance on the characteristics of patients with this condition, so a review was performed on diagnostic and therapeutic approaches to this entity.

METHODS {#sec2}
=======

We describe 15 patients with PPI due to *S. intermedius*. Using the key words "*Streptococcus intermedius* pleural infection" and "*Streptococcus intermedius* pulmonary infection" we searched MEDLINE (National Library of Medicine, Bethesda, MD), Web of Science, CINAHL, and Cochrane systematic review databases for case reports of this condition. We also checked the references cited in the papers for additional case reports published before 1966.

We traced 6 cases caused by *S. intermedius* and described in sufficient detail. These cases, along with our 9 patients, are the basis of the present report. Data on age and sex, risk factors or underlying diseases, time until diagnosis, clinical manifestations, radiological and laboratory findings, microbiologic diagnosis, treatment, outcome and follow-up were recorded over a period of two years (June 2015-June 2017).

In the microbiology laboratory the pleural fluid was processed as follows: after centrifugation, the sample was inoculated in blood agar (either aerobic or anaerobic) (BD Columbia Agar 5% Sheepblood^®^, Becton Dickinson), chocolate agar (BD Choco Agar, Becton Dickinson) and thioglycolate broth (BDTM Fluid Thioglycollate Medium, Becton Dickinson). All media were incubated at 37º C. A mass spectrometry method (Bruker Biotyper, Billerica, MA) was employed to identify the strain. All cases of *S. intermedius* infection in our laboratory were obtained in pure culture

RESULTS {#sec3}
=======

The first case of PPI due to *S. intermedius* here reviewed was published by Roy et al. in 1991 \[[@cit0005]\]. A review of the medical literature identified 29 cases of PPI caused by this pathogen. Fourteen cases were excluded because no individualized data were available \[[@cit0011]\]. This review therefore comprised 15 patients, including our cases.

General characteristics {#sec3-1}
-----------------------

[Table 1](#t0001){ref-type="table"} summarizes the clinical and microbiologic findings for the 15 patients, and [table 2](#t0002){ref-type="table"} compiles the features of pleural effusion. There were 12 (80%) men and the mean age of patients was 62.06 ± 15 years (range: 38-89 years). The mean interval from clinical onset to infection diagnosis was 34 days (range: 3 to 150 days). This interval was not reported for one patient \[[@cit0009]\].

###### 

Main findings in 15 patients with pleural effusion caused by *Streptococcus intermedius*.

  Patient (year of publication) Author \[reference\]   Age (years)/sex   Clinical manifestations                              Risk factors                                            Time until diagnosis (days)   Radiological findings                                               Laboratory findings                Microbiologic diagnostic   Antimicrobial treatment                                                        Other treatments                       Outcome/follow-up (months)
  ---------------------------------------------------- ----------------- ---------------------------------------------------- ------------------------------------------------------- ----------------------------- ------------------------------------------------------------------- ---------------------------------- -------------------------- ------------------------------------------------------------------------------ -------------------------------------- ----------------------------------------------------
  1 (1991) Roy \[[@cit0005]\]                          38/M              Chest pain, cough, dyspnea, fever, lightheadedness   Smoker Caries                                           7                             Large left pleural density                                          WBC 12,600/mm3                     Pleural fluid culture      Cefotaxime Penicillin                                                          Drainage Thoracotomy + decortication   Cure/NR
  2 (2000) Khatib \[[@cit0006]\]                       55/M              Fever, cough, hemoptysis, headache                   Alcoholic cirrhosis                                     10                            Right upper-lobe consolidation                                      NR                                 Lung biopsy culture        Ceftriaxone + ampicillin                                                       NR                                     Died
  3 (2000) Mautner \[[@cit0007]\]                      80/M              Chest pain, cough, fever, shortness of breath        Smoker                                                  14                            Left hemithorax opacification                                       WBC 22,000/mm^3^                   Pleural fluid culture      NR                                                                             Drainage Thoracotomy + decortication   NR
  4 (2006) Iskandar \[[@cit0008]\]                     52/M              Cough, shortness of breath, loss weight              Smoker Caries, gingivitis                               150                           Loculated pleural effusion                                          NR                                 Pleural fluid culture      Levofloxacin + clindamycin                                                     Drainage                               Cure/NR
  5 (2014) Noguchi \[[@cit0009]\]                      79/M              Fever, cough                                         Empyema 4 months ago Smoker Drinker Poor oral hygiene   NR                            Left hemithorax opacification                                       WBC 39,600/mm^3^ CRP 33,6 mg/dL    Pleural fluid culture      Meropenem                                                                      Drainage Pleurectomy                   Improved /NR
  6 (2016) Hannoodi \[[@cit0011]\]                     52/F              Cough, shortness of breath, fever                    Asthma Smoker                                           42                            Bilateral multilobular lung infiltrate Loculated pleural effusion   WBC 29,200/mm^3^                   Tissue sample culture      Erythromycin Ciprofloxacin Aztreonam + vancomycin + azithromycin Ceftriaxone   Drainage Pleurectomy + decortication   Cure/NR
  7 (PR) Cobo                                          75/M              Cough, dyspnea, chest pain, hemoptysis               Smoker Asthma COPD                                      5                             Right hemithorax opacification                                      WBC 24,000/mm^3^ CRP 200 mg/dL     Pleural fluid culture      Ceftriaxone Levofloxacin                                                       Drainage                               Cure/3
  8 (PR) Cobo                                          63/M              Cough, chest pain                                    DM Smoker COPD                                          7                             Pulmonary abscess and empyema Right hemithorax opacification        WBC 20,600/mm^3^ CRP 353.7 mg/dL   Pleural fluid culture      Ceftriaxone Levofl oxacin                                                      Drainage                               Cure/3
  9 (PR) Cobo                                          62/F              Fever, dyspnea                                       Smoker COPD Thoracic trauma                             2                             Right basal pulmonary opacification Pleural effusion                WBC 20,080/mm^3^                   Pleural fluid culture      Ceftriaxone Levofloxacin                                                       Drainage + pleural debridement         Cure/5
  10 (PR) Cobo                                         89/M              Increase of dyspnea, cough                           DM                                                      15                            Pulmonary empyema                                                   WBC 18,520/mm^3^ CRP 156.5 mg/dL   Pleural fluid culture      Ceftriaxone                                                                    Drainage                               Cure/NR
  11 (PR) Cobo                                         48/M              Dyspnea, fever, chest pain, cough, chills            Smoker Amigdalitis and cervical abscess                 5                             Pulmonary abscesses Bilateral pleural effusion                      WBC 3,130/mm^3^ CRP 480 mg/dL      Pleural fluid culture      Ceftriaxone Levofloxacin                                                       Drainage                               Died
  12 (PR) Cobo                                         72/M              Cough, dyspnea, chest pain                           Smoker Drinker                                          3                             Right basal opacification Pleural effusion                          WBC 21,210/mm^3^ CRP 284 mg/dL     Pleural fluid culture      Ceftriaxone Levofloxacin                                                       Drainage                               Improved/new pleural effusion 1 month later Cure/2
  13 (PR) Cobo                                         49/M              Chest pain, dyspnea, fever                           Smoker Drinker                                          7                             Right pleural effusion                                              WBC 40,000/mm^3^ CRP 33.7 mg/dL    Pleural fluid culture      Levofloxacin Clarithromycin Cefditoren Clindamycin                             Drainage                               Improved/new pleural effusion 15 days later
  14 (PR) Cobo                                         74/M              Chest pain, dyspnea                                  Smoker Drinker Pulmonary epidermoid carcinoma           6                             Right pleural effusion Nodular lesions in the right lung            WBC 15,100/mm^3^ CRP 80.2 mg/dL    Pleural fluid culture      Imipenem Ceftriaxone Clindamycin                                               Drainage                               Cure/1
  15 (PR) Cobo                                         43/F              Chest pain, cough, dyspnea                           Smoker                                                  4                             Left pleural effusion                                               WBC 12,400/mm^3^ CRP 256 mg/dL     Pleural fluid culture      Levofloxacin                                                                   Drainage                               Cure/2

M: male; F: female; NR: not reported; PR: present report; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; WBC: white blood count; COPD: chronic obstructive pulmonary disease; DM: diabetes mellitus

###### 

Pleural effusion characteristics from 13 patients with *S. intermedius* infection.

  Patient[^b^](#tf2-1){ref-type="fn"} (year of publication) Author \[reference\]   pH     Glucose (mg/dl)   Proteins (g/dl)   LDH (IU/L) LDH (IU/L) in blood^a^   WCC (mm^3^)/ % neutrophils
  -------------------------------------------------------------------------------- ------ ----------------- ----------------- ----------------------------------- ----------------------------
  1 (1991)                                                                         7.04   NR                NR                NR                                  370/NR
  Roy \[[@cit0005]\]                                                                                                                                              
  3 (2000)                                                                         6.89   5                 4.7               NR                                  2,900/96
  Mautner \[[@cit0007]\]                                                                                                                                          
  4 (2006)                                                                         NR     10                4.2               6280                                466,000/90
  Iskandar \[[@cit0008]\]                                                                                                     113^a^                              
  5 (2014)                                                                         NR     1                 4.3               2873                                NR
  Noguchi \[[@cit0009]\]                                                                                                      236^a^                              
  6 (2016)                                                                         NR     93                4                 1372                                NR
  Hannoodi \[[@cit0011]\]                                                                                                                                         
  7 (PR)                                                                           NR     1                 2.8               3540                                5,727/96
  Cobo                                                                                                                        198^a^                              
  8 (PR)                                                                           NR     32                3.5               4860                                63,298/95
  Cobo                                                                                                                        292^a^                              
  9 (PR)                                                                           NR     1                 3.9               1790                                44,924/92
  Cobo                                                                                                                        204^a^                              
  10 (PR)                                                                          NR     1                 1.7               687                                 295,000/54
  Cobo                                                                                                                        173^a^                              
  12 (PR)                                                                          NR     10                4.2               1535                                19,212/91
  Cobo                                                                                                                        211^a^                              
  13 (PR)                                                                          7.5    1                 5.2               2278                                45,800/85
  Cobo                                                                                                                        217^a^                              
  14 (PR)                                                                          7.07   26                4.8               4762                                38,552/82
  Cobo                                                                                                                        116^a^                              
  15 (PR)                                                                          7.2    74                4,7               571                                 2,549/32
  Cobo                                                                                                                        289^a^                              

NR: not reported; LDH: lactate dehydrogenase; ADA: adenosin-deaminase; WCC: white cells count

Normal values: pH: 7.37-7.45; Glucose: \>60 mg/dL; Proteins: 1-2 gr/dL; LDH: \<50% plasma value; WCC: 1000-5000/mm^3^.

Cases 2 and 11 did not reported any data about pleural effusion

No risk factors for Streptococcal infection were found in one patient (6.6%) 5. Major risk factors for Streptococcal infection were alcoholism in 5 (33.3%) patients, chronic obstructive pulmonary disease and periodontal disease in 3 (20%) cases each one, and diabetes mellitus in 2 (13.3%). Thirteen (86.6%) patients were smokers and 3 (20%) patients had more than one risk factor for this infection.

Empyema was seen in 7 (46.6%) patients, and both pneumonia and pleural effusion in 2 patients each one (13.3%).

Clinical manifestations {#sec3-2}
-----------------------

Cough was reported by 12 (80%) patients, and chest pain and dyspnea by 9 (60%) patients each one. Finally, fever was recorded in 8 (53.3%) patients. Five patients (33.3%) had two symptoms, while 10 (66.6%) had three or more symptoms.

Microbiology and laboratory findings {#sec3-3}
------------------------------------

At the diagnosis of PPI, data on C-reactive protein (CRP) level were not reported in 6 (40%) patients and data on white blood cell (WBC) were not reported in only 2 (13.3%). The mean CRP level was 208.6 mg/L (range: 33.6-480), and the mean WBC level was 21,418/mm^3^ (range: 3,130-40,000).

Regarding data on pleural fluid, protein level was elevated in all patients tested, except for one patient (case 10); the mean protein level was 4 g/dL (range: 1.7-5.2). LDH level was also elevated in all patients tested (n=11), being the mean LDH level 2777 g/dL (range 571-6280). Finally, the mean white cell count level was 89,484 mm^3^ (range 370-466,000).

*S. intermedius* was diagnosed by culture of pleural fluid (PF) aspirate in 13 (86.6%) cases, and culture of biopsy or tissue samples in 2 (13.3%).

Susceptibility tests for *S. intermedius* were reported in 12 (80%) isolates ([table 3](#t0003){ref-type="table"}). Antimicrobial susceptibility was completely performed in cases 7 to 15. In these 9 cases, 100% of isolates were susceptible to cefotaxime, levofloxacin, linezolid, vancomycin and daptomycin, and 45.5% of isolates were resistant to both clindamycin and erythromycin. Only one strain of *S. intermedius* was intermediate to penicillin (case 7; MIC 1 mg/L). In case 4, susceptibility to levofloxacin was reported, and in cases 5 and 6 susceptibility to penicillin was also reported.

###### 

Antimicrobial susceptibility in 9 strains of *S. intermedius*.

  Antibiotic                                 \% susceptibility
  ------------------------------------------ -------------------
  Cefotaxime                                 100
  Clindamycin                                55.5
  Erythromycin                               55.5
  Levofloxacin[^a^](#tf3-1){ref-type="fn"}   100
  Linezolid                                  100
  Penicillin[^b^](#tf3-2){ref-type="fn"}     90,9
  Vancomycin                                 100
  Daptomycin                                 100

Including the strain of Iskandar et al.

Including the strains of Noguchi et al. and Hannoodi et al.

Antimicrobial and surgical treatment {#sec3-4}
------------------------------------

Fourteen (93.3%) patients underwent antibiotic treatment, with a single drug in 2 cases (14.2%), with two drugs in 8 cases (57.1%) and more than two in 3 (21.4%). Ceftriaxone plus levofloxacin was the antimicrobial regimen most used (5/35.7%).

Drainage of PF was performed in all patients, 9 of whom (60%) underwent only this procedure. Thoracotomy plus decortication was undertaken in 2 (13.3%) patients and pleurectomy in another 2 cases. Debridement was undergone only in one (6.6%) patient.

Outcome {#sec3-5}
-------

The final outcome was not reported in one patient, and a favourable outcome was recorded in 12 (80%) patients after antibiotic plus surgical treatment. Two patients (13.3%) died. The follow-up was reported in 6 (40%) patients, with a mean time of 2.6 months (range 1-5 months).

DISCUSSION {#sec4}
==========

SAG is part of the normal biota of the oropharyngeal, urogenital, and gastrointestinal tracts \[[@cit0012]\]. These microorganisms are strongly associated with abscess formation in the brain, peritoneal cavity, and oropharynx \[[@cit0013]\], although *S. intermedius* and *S. constellatus* are generally more frequently associated with abscess formation than *S. anginosus* \[[@cit0014]\]. Moreover, it is well known that *S. anginosus* is frequently found in specimens from the urogenital or gastrointestinal tracts and *S. constellatus* can be found in infections of the respiratory tract or blood, as well as *S. intermedius* is most often identified in abscesses of the brain or liver \[[@cit0015]\].

PPI caused by *S. intermedius* is an uncommon event. Only few case reports with this condition have been published until now \[[@cit0005]-[@cit0010]\], and other report found some cases of this infection in a period of 10 years \[[@cit0011]\]. However, in our hospital we were able to trace 9 cases of PPI caused by this microorganism in the last 3 years, showing an increase of incidence of this infection in our health area. The main cause of this increase is unknown, but the use of new diagnostic tools such as MALDI-TOF techniques may be related to a better identification.

Risk factors for *S. intermedius* infection, including periodontal disease, diabetes mellitus, alcoholism and COPD \[[@cit0016]\] were recorded in 14 patients and may play an important role in the development of these infections. Moreover, 13 patients were smokers and, although the smoker status is not strictly a risk factor for this infection, this condition may lead to produce COPD in the future and to contribute to the infection. Once *S. intermedius* have entered the body, their pathogenicity has been attributed to their trend to form abscesses and suppurated infections \[[@cit0013],[@cit0015]\].

Several mechanisms for *S. intermedius* infections have been suggested; among others, aspiration of oral secretions is of particular importance especially in elderly patients. Regarding to this fact, it has been reported that *S. intermedius* infection tend to be more frequently produced in older patients. However, the mean age of *S. intermedius* infection in this series was 62 years and 7 patients here included were in their fifties or less, indicating the involvement of other factors in triggering the infection. On the other hand, *S. intermedius* tended to be more frequently detected in male patients \[[@cit0016]\]; in the present manuscript 12 from 15 patients were male. The reasons for the gender differences remain unclear, and further studies will be necessary to elucidate it.

According to our results, cough, chest pain and dyspnea are the main symptoms of PPI due to *S. intermedius*. Moreover, the onset of symptoms and development of the disease is generally rapid. Based on data for 14 patients, the mean time between onset of symptoms and PPI diagnosis was 34 days.

CRP level has a good sensitivity but it is limited by it poor specificity. Out of 9 patients in the present series for whom CRP studies were requested, all cases had CRP \> 30 mg/L, which might suggest the presence of infection. In the majority of cases, the CRP level was elevated with a mean value of 208 mg/L. Also, the number of WBC was also elevated in almost all cases with a mean value of 21,400 cells/mm^3^.

Characteristics of PF were also analyzed. In patients in whom proteins, LDH and WCC levels were reported, in almost all of them the levels of these markers were increased (see [table 2](#t0002){ref-type="table"}). The mean values of proteins, LDH and WCC were 4 mg/dL, 2777 IU/L and 89,484 cells/mm^3^ respectively. In the same way, the glucose levels were diminished, except in two cases (case 6 and 15) and the mean value was 21.25 mg/dL.

Treatment of infections due to *S. intermedius* should be guided by susceptibility studies although some clinical laboratories do not routinely perform antimicrobial susceptibility testing for these pathogens. *S. intermedius* as well as other members of the SAG are generally susceptible to β-lactam agents. The treatment of choice for these infections has not yet been established but ceftriaxone seems to be the preferred antimicrobial used due to both an excellent activity and tissue penetration. Regarding penicillin susceptibility, some strains intermediate with this antibiotic have been reported, and there are rare strains with resistance to penicillin \[[@cit0017]\]. Penicillin-intermediate or -resistant strains are more likely to be *S. anginosus* or *S. intermedius* than *S. constellatus* \[[@cit0017]\]. If allergy or resistance to β-lactam agents may be demonstrated, vancomycin is an appropriate alternative to treatment. Overall, fluoroquinolones are susceptible to SAG although MICs are high, but these microorganisms tend to develop resistance quickly and seems to be not appropriate for empirical treatment \[[@cit0018]\]. Most strains of the SAG are resistant to aminoglycosides and macrolide resistance appears to be increasing \[[@cit0017],[@cit0019]\]. In the present study, 100% of susceptibility was obtained for cefotaxime, levofloxacin, linezolid, vancomycin and daptomycin, whereas only 55% of susceptibility was found for erythromycin and clindamycin. Only one isolate was intermediate to penicillin. Overall, susceptibility to several antibiotics is shown and antibiotic resistance in *S. intermedius* may be initially not considered a problem, although monitoring through susceptibility testing is advisable.

In the majority of cases, the diagnosis was carried out by culture of PF. In fact, drainage of pleural effusion was performed in all patients; other surgical procedures were pleurectomy, thoracotomy, decortication, and debridement.

The outcome was generally favourable and cure was documented in 10 patients. Two patients improved of the disease and in two cases the treatment fails and finally died as a consequence of the infection.

PPIs caused by *S. intermedius* are uncommon infections with few cases published in the medical literature. These infections tend to occur in males, smokers and with different risk factors such as periodontal diseases, alcoholism and COPD. The diagnosis may be suspected by elevation of CRP and WBC and must be confirmed microbiologically, taking samples of pleural fluid and/or lung tissue. Antimicrobial susceptibility testing of *Streptococcus* strains is also highly recommended. The association of antimicrobial drugs with drainage of pleural effusion is recommended to eradicate the infection.
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